One of the most widely followed is Stanley Druckenmiller, who ran Duquesne Capital Management for nearly 30 years with an impeccable track record of generating an average annual return of 30%. Druckenmiller’s biggest buy in the quarter was Natera (NASDAQ: NTRA), in which he nearly doubled his stake, adding 1.59 million shares of the healthcare diagnostics company, known for a pre-natal diagnostic called Panorama that screens for fetal abnormalities. Coupang (NYSE: CPNG) has been a top holding of Druckenmiller’s since he began buying the stock in 2021.